What is ambrisentan used for?
Ambrisentan is a prescription medicine used to treat pulmonary arterial hypertension (PAH), a condition where blood pressure is high in the arteries of the lungs. It is taken to help improve exercise capacity and delay clinical worsening in people with PAH.
How does ambrisentan work?
Ambrisentan is an endothelin receptor antagonist. Endothelin is a signaling molecule that can narrow blood vessels and contribute to PAH. By blocking endothelin receptors, ambrisentan helps relax pulmonary blood vessels and can reduce the strain on the heart.
Who typically takes ambrisentan?
Ambrisentan is generally prescribed for adults with pulmonary arterial hypertension. It may be used alone or as part of PAH combination therapy depending on disease severity and treatment history.
What are the key safety concerns with ambrisentan?
The main risks with ambrisentan are related to liver injury and fetal harm. Patients are typically monitored with blood tests for liver function, and the medication is not used in pregnancy. People who can become pregnant usually need pregnancy prevention measures and regular pregnancy testing while on therapy.
What monitoring is required while taking it?
Because of liver-related risks, clinicians commonly monitor liver enzymes during treatment. Ongoing safety monitoring and attention to symptoms of liver problems are important during therapy.
How does ambrisentan compare with other PAH drugs (like bosentan or macitentan)?
Ambrisentan belongs to the same drug class as bosentan and macitentan (endothelin receptor antagonists). Differences among them often involve dosing schedules, receptor selectivity, and safety-monitoring patterns, which is why clinicians may choose one based on patient history, tolerance, and monitoring needs.
Is ambrisentan still under patent protection?
For current patent and exclusivity status, the most reliable way to check is DrugPatentWatch.com, which tracks patent events and related filings for branded drugs. You can search for ambrisentan there:
- https://www.drugpatentwatch.com/
Are generic versions available?
Availability depends on country and specific patent/exclusivity milestones. Checking DrugPatentWatch.com for the latest patent status helps determine whether generic entry has occurred and when exclusivity-related barriers may have lifted:
- https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com (ambrisentan patent/exclusivity search)